Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says.Watch here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPageGroup Regulatory News (PAGE)

Share Price Information for PageGroup (PAGE)

Share Price is delayed by 15 minutes
Get Live Data
104.30    1.20 (1.16%)
Bid:
104.20
Ask:
104.60
Spread: 0.40 (0.384%)
Market Cap: £324.75m
PAGE Live PriceLast checked at - London Stock Exchange

Intraday PageGroup Share Chart

Director/PDMR Shareholding

13 Mar 2015 15:56

RNS Number : 4479H
Michael Page International PLC
13 March 2015
 



 

 

Michael Page International plc (the "Company")

 

 

Notification of Interests of Directors and Persons Discharging Managerial Responsibility ("PDMRs")

 

Vesting of Shares Under The Michael Page International plc Annual Bonus Plan 2004

 

On 12 March 2015 UBS Trustees (Jersey) Limited, the trustee of the Michael Page Employees' Benefit Trust ("EBT") transferred the legal title to the number of Ordinary shares of 1p in the Company (the "Shares") as set out in the table below to Steve Ingham, CEO of the Company, for nil cost, as a result of the vesting of his allocation under The Michael Page International plc Annual Bonus Plan. Of these, the trustee of the EBT arranged for the sale of sufficient of such Shares on behalf of Mr Ingham in order to reimburse the Company for his personal tax and national insurance contributions arising. The number of Shares sold and transferred was as follows:-

 

Name of Director

Total No of Shares Transferred on 12 March 2015

No of Shares Sold on 12 March 2015

Price Per Share sold on 12 March 2015

No of Shares Retained

Steve Ingham

8,631

4,085

£5.04397

4,546

 

 

Vesting of Shares Under The Michael Page International plc Incentive Share Plan 2004

 

On 12 March 2015 UBS Trustees (Jersey) Limited, the trustee of the EBT transferred the legal title to the number of Ordinary shares of 1p in the Company (the "Shares") as set out in the table below, for nil cost, as a result of the vesting of their allocations under the deferred element of The Michael Page International plc Incentive Share Plan 2004.

 

The number of shares sold and transferred is as follows:-

 

Name of Director* or PDMR

Total No of Shares Transferred on 12 March 2015

No of Shares Sold on 12 March 2015

Price Per Share sold on 12 March 2015

No of Shares Retained

Steve Ingham*

82,011

38,817

£5.04397

43,917

Gary James

45,423

Nil

-

45,423

Fabrice Lacombe

41,929

41,929

£5.04397

Nil

Patrick Hollard

48,917

227

£5.04397

48,690

Oliver Watson

41,929

19,855

£5.04397

22,074

 

The performance element of the above awards lapsed.

 

Exercise of Options Under The Michael Page International plc Incentive Share Plan 2004

 

On 12 March 2015 the PDMR set out in the table below exercised his nil cost Deferred Option Award under The Michael Page International plc Incentive Share Plan 2004.

 

The number of shares sold and transferred is as follows:-

 

Name of PDMR

No of Deferred Options Exercised

No of Shares Sold on 12 March 2015

Price Per Share sold on 12 March 2015

Olivier Lemaitre

48,917

48,917

£5.00689

 

The Performance Option Award lapsed.

 

 

 

 

Exercise of Options under the Michael Page International plc Executive Share Option Scheme

 

On 11 March 2015 the undermentioned PDMRs exercised options as detailed in the table below under The Michael Page International plc Executive Share Option Scheme. The number of options exercised and shares sold were as follows:-

 

Name of PDMR

Total No of Options exercised

No of Shares Sold on 12 March 2015

Price Per Share sold on 12 March 2015

Fabrice Lacombe

350,000

350,000

£4.98484

Olivier Lemaitre

300,000

300,000

£5.00256

 

Sale of Ordinary Shares

 

On 11 March 2015 Annabel Watson, connected person to Oliver Watson, a PDMR, sold 80,000 Ordinary shares in the Company at a price of £5.00.

 

This announcement is made in accordance with DTR3.1.4 R(1).

 

 

 

Elaine Marriner - Company Secretary Tel 01932 264148

Ross Hawley - Director of Investor Relations Tel: 020 3077 8425

 

 

13 March 2015

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSSFIFIDFISEID
Date   Source Headline
8th Aug 20247:00 amRNSHalf Year Results for the Period Ended 30 June 24
6th Aug 20249:48 amRNSNotice of 2024 Half Year Results
9th Jul 20247:00 amRNSSECOND QUARTER 2024 TRADING UPDATE
10th Jun 20243:28 pmRNSDirector Declaration
3rd Jun 20241:50 pmRNSResult of AGM
15th Apr 20247:00 amRNSTrading Update
12th Apr 20243:48 pmRNSAnnual Report & Accounts & Notice of AGM
11th Apr 202411:18 amRNSHolding(s) in Company
11th Apr 20249:30 amRNSNotice of First Quarter 2024 Trading Update
18th Mar 20242:20 pmRNSDirector/PDMR Shareholding
18th Mar 20242:15 pmRNSDirector/PDMR Shareholding
13th Mar 202412:17 pmRNSDirector/PDMR Shareholding
7th Mar 20247:00 amRNSFull Year Results for the Year Ended 31 Dec 2023
4th Mar 20243:18 pmRNSNotice of 2023 Full Year Results
15th Jan 20247:00 amRNSTrading Update
11th Jan 20249:43 amRNSNotice of Q4 and Full Year 2023 Trading Update
27th Nov 20231:59 pmRNSHolding(s) in Company
11th Oct 20237:00 amRNSQ3 Trading Statement
10th Oct 20239:53 amRNSNotice of Third Quarter 2023 Trading Update
27th Sep 20233:00 pmRNSHolding(s) in Company
20th Sep 20237:00 amRNSCapital Markets Event
7th Aug 20232:52 pmRNSHolding(s) in Company
7th Aug 20237:00 amRNSHalf Year Results for the Period Ended 30 June 23
2nd Aug 20234:27 pmRNSNotice of 2023 Half Year Results
20th Jul 20232:18 pmRNSHolding(s) in Company
18th Jul 20233:23 pmRNSHolding(s) in Company
18th Jul 20231:57 pmRNSHolding(s) in Company
12th Jul 202311:27 amRNSHolding(s) in Company
12th Jul 20237:00 amRNSTrading Update
10th Jul 202310:18 amRNSNotice of Second Quarter 2023 Trading Update
20th Jun 20233:36 pmRNSHolding(s) in Company
14th Jun 202311:51 amRNSHolding(s) in Company
6th Jun 20237:00 amRNSInteractive Investor Event
1st Jun 20231:47 pmRNSResult of AGM
19th Apr 20234:25 pmRNSHolding(s) in Company
17th Apr 20237:00 amRNSQ1 Trading Statement
13th Apr 20232:19 pmRNSNotice of First Quarter 2023 Trading Update
13th Apr 202310:35 amRNSAnnual Report & Accounts & Notice of AGM
3rd Apr 20235:42 pmRNSHolding(s) in Company
24th Mar 202310:41 amRNSDirector/PDMR Shareholding
23rd Mar 202312:45 pmRNSHolding(s) in Company
16th Mar 202312:34 pmRNSDirector/PDMR Shareholding
16th Mar 202312:28 pmRNSDirector/PDMR Shareholding
14th Mar 202312:37 pmRNSDirector/PDMR Shareholding
14th Mar 202312:35 pmRNSDirector/PDMR Shareholding
9th Mar 20237:00 amRNSFull Year Results for the Year Ended 31 Dec 2022
7th Mar 20235:37 pmRNSBoard Changes
2nd Mar 20231:55 pmRNSNotice of 2022 Full Year Results
11th Jan 20237:00 amRNSFOURTH QUARTER AND FULL YEAR 2022 TRADING UPDATE
9th Jan 20232:23 pmRNSNotice of Q4 and Full Year 2022 Trading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.